PRODUCT

The first step in the LE LIFT PRO protocol, CONCENTRÉ CONTOURS helps address advanced signs of aging, redefine the look of facial contours and rebalance contrast. This enveloping serum also delivers an instant tensing effect. Fragrance-free and suitable for all skin types, including sensitive, the formula can be applied between aesthetic dermatological procedures to help maintain results*. Immediately after application, the complexion looks 30%** more radiant. After 2 months, skin appears 39%*** more lifted and facial volume looks 36%*** more defined.

The LE LIFT PRO protocol: a skincare line that helps restore the look of the youth triangle, the area from the high points of the cheeks to the tip of the chin, which inverts with age. Each formula features potent melipona enzymatic ingredient.

KEY INGREDIENTS

Cultivated at the CHANEL open-sky laboratory in Costa Rica, melipona enzymatic ingredient is a precious honey sourced from a supply network developed in partnership with Alianza Campesina Flora Nueva, which protects melipona bees and local biodiversity while also contributing to the producers’ economic development. This highly concentrated ingredient helps reinforce skin’s support and correct the appearance of advanced signs of aging. A breakthrough biopolymer instantly tightens the look of skin, while hyaluronic acid provides long-lasting hydration.

HOW TO APPLY

Inspired by techniques used for decades in aesthetic dermatology to promote resiliency, CHANEL has created massage gestures to complement the LE LIFT PRO protocol. Before applying the product, perform the signature LE GESTE LIFT PRO technique: Begin with deep pinching movements across the cheeks and jawline. Repeat 3 times. Then, use your thumb and index finger to lightly pinch expression lines perpendicularly. Use auto-fill dropper to dispense the perfect amount of product and apply to entire face.

*Not suitable for use pre- or post-procedure. Consult your doctor before using.
**Clinical evaluation of 31 women immediately after application
***Clinical evaluation of 31 women after 2 months of use